Friday, October 14, 2016 9:34:36 AM
Remember there is no revenue for the next 2 plus years minimum. Several other trials have to be started and completed over the next four years before this will be considered a winner. Then you have the other factors such as retiring chief medical officer, the election, the fed signaling that they are raising the rate which will effect the global markets, minimal information comes from the company leaving investors with nothing, and an executive staff and board of directors that are not purchasing the stock of the company that employs them. They do enjoy handsome salaries, benefits, stock options, and other perks.
You never did tell me based on your model what year NVIV would have a market cap of 600 million.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM